May 1, 2001Clinical ChemistryOpen Access

New Generation Cardiac Troponin I Assay for the Access Immunoassay System

View Full Paper

Ask AI

Bookmark

Structured PICO

Population

192 subjects total: 70 patients admitted to the Coronary Care Unit for suspicion of acute coronary syndrome with increased myocardial markers (creatine kinase-MB and troponin I), and 122 apparently healthy subjects (70 women, 52 men; median age 41 years, range 26-73 years).

Intervention

New generation ACCESS cardiac troponin I (cTnI) assay (Beckman Coulter)

Outcome

Analytical performance of the new generation Access cTnI assay and values in apparently healthy subjectssurrogate

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support sensitive troponin assays for risk stratification in unstable angina; leaves open prospective validation before clinical adoption.

Cite This Study

Venge et al. (2001) studied this question.

synapsesocial.com/papers/6a13d2b033810aaadff1af0a https://doi.org/10.1093/clinchem/47.5.959

View Full Paper

Ask AI

Bookmark

Implication

May support sensitive troponin assays for risk stratification in unstable angina; leaves open prospective validation before clinical adoption.

New Generation Cardiac Troponin I Assay for the Access Immunoassay System

Structured PICO

Discussion

Implication

Cite This Study

New Generation Cardiac Troponin I Assay for the Access Immunoassay System

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider